MED1 and cancer: Moreover, selective inhibition and knockdown of cyclin-dependent kinase 7 (CDK7) as well as knockdown of its phosphorylation target the MED1 subunit of the Mediator complex [42] induce both NEAT1_2 splicing and read-through transcription in cancer cell lines.